After years of enforcement discretion, the U.S. Food and Drug Administration (FDA) published a proposed rule on October 3, 2023 under which the agency articulated its intent to increase regulatory oversight of laboratory developed tests (LDTs).

If the proposed rule is finalized without changes, FDA will regulate all LDTs as medical devices. Comments to the…